Tachykinins, an evolutionary conserved family of peptide hormones in both invertebrates and vertebrates, are produced by neuronal cells as inactive preprotachykinins that are post-translationally processed into different neuropeptides such as substance P, neurokinin A, and neurokinin B. We show here that furin-mediated cleavage of the bovine respiratory syncytial virus fusion protein results in the release of a peptide that is converted into a biologically active tachykinin (virokinin) by additional posttranslational modifications. An antibody directed to substance P cross-reacted with the C terminus of mature virokinin that contains a classical tachykinin motif. The cellular enzymes involved in the C-terminal maturation of virokinin were found to be present in many established cell lines. Virokinin is secreted by virus-infected cells and was found to act on the tachykinin receptor 1 (TACR1), leading to rapid desensitization of this G protein-coupled receptor as shown by TACR1-green fluorescent protein conjugate translocation from the cell surface to endosomes and by co-internalization of the receptor with -arrestin 1-green fluorescent protein conjugates. In vitro experiments with isolated circular muscle from guinea pig stomach indicated that virokinin is capable of inducing smooth muscle contraction by acting on the tachykinin receptor 3. Tachykinins and their cognate receptors are present in the mammalian respiratory tract, where they have potent effects on local inflammatory and immune processes. The viral tachykinin-like peptide represents a novel form of molecular mimicry, which may benefit the virus by affecting the host immune response.
Bovine respiratory syncytial virus (BRSV)1 and human respiratory syncytial virus (HRSV), two closely related RNA viruses of the family Paramyxoviridae, replicate in the lower respiratory tract, causing similar diseases in their respective hosts (1). Young calves and infants are particularly affected and suffer from obstructive bronchitis, wheezing, and hypoxemia. Damage of respiratory epithelial cells due to the infection itself probably plays a minor role in RSV pathogenesis (2). Rather, the inflammatory response triggered by cellular chemokines and cytokines that are released from RSV-infected epithelial cells and lymphocytes is believed to contribute to the severity of the disease (3-9).Several observations indicate that the adaptive immune response to RSV is incomplete and of short duration. Maternally derived virus-neutralizing antibodies do not provide sufficient protection from infection (10, 11). Reinfections, even by RSV of the same serogroup, occur repeatedly during childhood and throughout life (12, 13). There is also evidence that infection with HRSV contributes to increased airway hyperresponsiveness and asthma (14 -17). Recent data suggest that RSV has immunosuppressive properties. In the mouse model, HRSV infection causes suppression of lung CD8 ϩ T-cell effector activity and inhibition of pulmonary CD8 ϩ T-cell memory development (18). In BRSV-infected la...